Gateway's sale of Healthway Medical notes to third parties raises eyebrows
Singapore
AHEAD of Healthway Medical Corporation's (HMC) extraordinary general meeting (EGM) to vote on the second tranche of S$60 million convertible notes, some minority shareholders have raised concerns whether private-equity fund Gateway Partners is there to make a quick buck at their expense.
Questions have risen over why Gateway chose to sell its first tranche of S$10 million in convertible notes to third parties after Lippo-linked Gentle Care has made an offer to buy over these notes at the same price it is offering to pay for each share of HMC.
TRENDING NOW
Profit with purpose: Kim Choo Kueh Chang’s pivot from public listing to protecting heritage
Singapore Kitchen CEO, senior manager charged with alleged fraud, falsifying accounts; both to stay in jobs for now
Record Singapore-US rate gap may widen further on inflows and hawkish Fed outlook
Marco Polo Marine shares plans to unlock value as boutique fund manager becomes substantial shareholder